We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HAIN:NASDAQThe Hain Celestial Group, Inc. Analysis

Data as of 2026-05-19 - not real-time

$0.74

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading at $0.74, well below its 20‑day (≈$0.77) and 50‑day (≈$0.75) simple moving averages and far under the 200‑day SMA (≈$1.17), indicating a technical oversold condition. Momentum indicators are mixed: RSI sits near 48 (neutral), while the MACD histogram turned positive and the MACD line crossed above its signal, signaling a tentative bullish shift. Volume has been decreasing and the 30‑day volatility exceeds 120%, reflecting a highly erratic price environment. On the fundamentals side, revenue is contracting (‑13% YoY) and the company posted a sizable loss margin (‑35%), with a debt‑to‑equity ratio above 260%, yet free cash flow remains positive and the DCF model suggests a fair value of roughly $11.6, implying >80% upside. Recent news of a “strategic overhaul” and upcoming Q3 earnings release have sparked a modest share surge, and the market sentiment index reads “Extreme Greed.”
Overall, the stock presents a classic value paradox: deep discount to intrinsic estimates but encumbered by weak profitability, high leverage, and pronounced price volatility. Investors must weigh the potential upside from a turnaround against the substantial execution and financial risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near recent support at $0.55
  • Bullish MACD crossover suggests limited near‑term upside
  • High volatility and decreasing volume increase short‑term uncertainty

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF‑derived upside of >80% versus current price
  • Strategic overhaul may improve margin trajectory
  • Forward EPS turning positive indicates potential earnings recovery

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Deep discount to book (P/B ≈0.2) offers value cushion
  • Consumer‑defensive positioning in organic/natural foods supports secular growth
  • Resolution of debt load and sustained cash flow generation are critical catalysts

Key Metrics & Analysis

Financial Health

Revenue Growth-13.30%
Profit Margin-35.47%
P/E Ratio7.0
ROE-113.04%
ROA1.39%
Debt/Equity276.41
P/B Ratio0.2
Op. Cash Flow$64.2M
Free Cash Flow$122.9M

Technical Analysis

TrendNeutral
RSI47.7
Support$0.55
Resistance$0.97
MA 20$0.77
MA 50$0.75
MA 200$1.17
MACDBullish
VolumeDecreasing
Fear & Greed Index89.61

Valuation

Fair Value$11.58
Target Price$1.34
Upside/Downside80.44%
GradeUndervalued
TypeValue

Risk Assessment

Beta2.12
Volatility123.34%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.